Is there any relationship between cardiovascular risk markers and young women with diminished ovarian reserve?

Gynecological Endocrinology

Volumn 30, Issue 10, 2014, Pages 697-700

  Verit, Fatma Ferda ^a   Keskin, Seda ^a   Omer, Beyhan ^b   Yalcinkaya, Sener ^a   Sakar, Nafi ^a  

^a ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Cardiovascular risk; Diminished ovarian reserve; Dyslipidemia; Insulin resistance

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIMINISHED OVARIAN RESERVE; DISEASE DURATION; DISEASE MARKER; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; OVARY INSUFFICIENCY; PREGNANCY; PROSPECTIVE STUDY; TREATMENT DURATION; BLOOD; CARDIOVASCULAR DISEASE; OVARIAN RESERVE; PHYSIOLOGY; RISK;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFERTILITY, FEMALE; OVARIAN RESERVE; RISK;

EID: 84907439605     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.922948     Document Type: Article

References (32)

1. Wang TT, Ke ZH, Song Y, Chen LT, et al. Identification of a mutation in GDF9 as a novel cause of diminished ovarian reserve in young women. Hum Reprod 2013;28:2473-81.
2. Nikolaou D, Templeton A. Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod 2003; 18:1137-9.
3. Bevc S, Sabic S, Hojs R. Atherosclerosis in hemodialysis patients - the role of microinflammation. Ren Fail 2008;30:1012-16.
4. Ikonomidis I, Stamatelopoulos K, Lekakis J, et al. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008;199: 3-11.
5. Kaptoge S, Di Angelantonio E, Lowe G, et al. Emerging risk factors collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant metaanalysis. Lancet 2010;375:132-40.
6. van Wijk DF, Boekholdt SM, Wareham NJ, et al. C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study. Arterioscler Thromb Vasc Biol 2013;33:2888-94.
7. Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7.
8. Farin HM, Abbasi F, Kim SH, et al. The relationship between insulin resistance and dyslipidaemia in cigarette smokers. Diabetes Obes Metab 2007;9:65-9.
9. Kemp DM. Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota? Adipocyte 2013;2:188-90.
10. Aroor A, McKarns S, Nistala R, et al. DPP-4 Inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renal insulin resistance in obesity and diabetes. Cardiorenal Med 2013;3:48-56.
11. Wellons M. Cardiovascular disease and primary ovarian insufficiency. Semin Reprod Med 2011;29:328-41.
12. Torng PL, Su TC, Sung FC, et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight - the Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis 2002;161:409-15.
13. Spencer CP, Godsland H, Stevenson JC. Is there a menopausal metabolic syndrome? Gynecol Endocrinol 1977;11:341-55.
14. Kahapola Arachchige KM, Wardrop R, et al. Waiting for an elevated FSH - too late a marker of reduced ovarian reserve? Aust N Z J Obstet Gynaecol 2012;52:460-4.
15. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart association task force on practice guidelines. Circulation 2013. [Epub ahead of print].
16. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
17. Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
18. Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and allcause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003;157:923-9.
19. de Boer EJ, den Tonkelaar I, te Velde ER, et al. OMEGA-project group. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 2003;18:1544-52.
20. de Boer EJ, den Tonkelaar I, te Velde ER, et al.; OMEGA-project group. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77: 978-85.
21. Pal L, Zhang K, Zeitlian G, Santoro N. Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril 2010;93:1074-9.
22. Greenseid K, Jindal S, Zapantis A, et al. Declining ovarian reserve adversely influences granulosa cell viability. Fertil Steril 2009;91: 2611-15.
23. Matthews KA, Wing RR, Kuller LH, et al. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-Aged healthy women. Arch Intern Med 1994;154:2349-55.
24. Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod 2003;18:1570-3.
25. Bleil ME, Gregorich SE, McConnell D, et al. Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? Menopause 2013;20:1139-46.
26. Gaikwad S, Garrido N, Cobo A, et al. Bed rest after embryo transfer negatively affects in vitro fertilization: a randomized controlled clinical trial. Fertil Steril 2013;100:729-35.
27. Loftis JM, Huckans M, Morasco BJ. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 2010;37:519-33.
28. Khovidhunkit W, Kim M, Memon R, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45:1169-96.
29. Rizzo M, Rizvi AA, Rini GB, Berneis K. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetol 2009;46:1-11.
30. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000;106:453-8.
31. Hansson GK. Atherosclerosis - an immune disease: the Anitschkov Lecture 2007. Atherosclerosis 2009;202:2-10.
32. Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001;86:2453-5.